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Background

Results

Discussion

Dementia encompasses multiple disease processes that involve loss
in cognitive functions such as memory, attention, thinking, and/or
language. It is estimated that 5.8 million Americans live with
Alzheimer’s disease, which accounts for 60-80% of all cases of
dementia. That number is expected to increase to 13.8 million in
2050.1

234 encounters from the dataset, representing 143 unique patient
charts, were reviewed. Three encounters were excluded from
statistical analyses because on three separate occasions, duplicate
MMSEs were documented for the same encounter.

Within the AWV, 2 patients received new diagnoses and 7 patients
received referrals to specialists. This suggests that as many as 9 of
103 patients (8.7%) were newly recognized as having dementia.
However, since this study excluded AWVs not associated with a
MoCA or MMSE, this diagnosis rate is likely falsely elevated.

Early diagnosis of dementia is essential in providing both patients
and their families with better care. However, it can sometimes be
difficult to differentiate between normal aging and a pathologic
decline in cognitive function, and 27-81% of patients with dementia
remain undiagnosed in a primary care setting.2,3,4

The median patient age at the time of assessment was 76 years.
Both the MoCA and MMSE are scored out of 30, with a score of 26
and above considered normal. The mean score for MoCAs and
MMSEs administered was 24, while the median was 26.

MoCA and MMSE administration settings

It was anticipated that detection of cognitive impairment would
improve with the Medicare Annual Wellness Visit (AWV), which
became effective in 2011. Beside a number of required components
such as the Health Risk Assessment (HRA), the AWV also requires
assessment of cognitive impairment by “direct observation, with due
consideration of information obtained by way of patient report,
concerns raised by family members, friends, caretakers, or others.”5
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Future directions
• Shorter and easier to administer screening tools may be more
suited to the AWV that longer diagnostic assessments such as
the MoCA or MMSE. The GPCOG (General Practitioner
Assessment of Cognition), Mini-Cog, and MIS (Memory
Impairment Screen) all take 5 minutes or less to administer and
can easily be used to identify at-risk patients.9
• Create flowsheets in the electronic medical record (EMR) that
prompt providers to administer certain tests, such as the MiniCog
• Utilize more sophisticated tools integrated into the EMR that help
leverage available data to identify high-risk patients who have
not yet scheduled an AWV, and who would benefit most from
cognitive screening.
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The extent to which the AWV has impacted dementia diagnosis and
care remains unclear. A recent study found that although AWVs
correlated with increase in some measures of lab testing for
reversible causes of cognitive impairment, they did not have a
substantial effect on its detection; only 6% of the AWV cohort
received an incident Mild Cognitive Impairment (MCI) or dementia
diagnosis.6

Problem Statement

This project focuses on the Health Systems competency of SELECT,
and aims to evaluate the dementia diagnosis gap in the context of a
Medicare intervention. There are a number of reasons why the AWV
has failed to substantially increase diagnosis of dementia.
• Inadequate uptake of the AWV by Medicare users: in 2014, only
15.6% of eligible Medicare users had an AWV, and the most
vulnerable patients were least likely to make an appointment.7,8
• Incorrect use of cognitive assessments
• Time constraints within the AWV
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Primary Care (AWV)

Primary Care (non-AWV)

Specialty (geriatrics, neurology)

Hospital (PT, OT)

Of the 231 encounters analyzed, primary care visits accounted for
151 (66%) encounters. 131 of the 151 primary care encounters were
AWVs, representing 103 unique patient charts.
All assessments conducted at AWVs were MMSEs. The median
score was 28/30.

Conclusions

This study examines how the Medicare Annual Wellness Visit (AWV)
has impacted dementia diagnosis and follow-up in a community health
network setting.

•

Methods

•
•

This was a retrospective chart review conducted at family medicine
and internal medicine practices within LVHN. Data were extracted
from electronic medical records on EPIC.
The data came from patients who had completed at least one AWV
between 1/1/2017 and 6/16/2019. From those patients came two
categories:
1. Patients who had completed an AWV and had an associated HRA
flowsheet (78,652 patient encounters)
2. Patients who had completed at least one Folstein Mini-Mental
Exam (MMSE) or Montreal Cognitive Assessment (MoCA), either
within the setting of the AWV or not (8,583 patient encounters)
While these two subsets were treated as separate, there was some
overlap as some of the encounters with an HRA flowsheet also had
an associated MoCA or MMSE. The HRA flowsheet is comprised of
several questions, including “Do you or any of your friends or family
members have any concerns about your memory?”

•
42 of the tests done at AWVs resulted in abnormal scores (less than
26/30). 3 tests were administered incorrectly and had falsely low
scores. 2 patients had abnormal scores that were attributed to other
processes, such as depression or grief. 12 patients with no
preexisting diagnosis of dementia received abnormal scores and
apparently no follow-up.

Outcomes of abnormal MMSE scores at AWVs
18
16

16

Data were analyzed using Microsoft Excel. The project was classified
as Quality Improvement and did not require Institutional Review
Board oversight.
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Chart review was performed on the subset of data that included all
encounters with associated MoCAs or MMSEs. Encounters were
coded into:
• Provider type categories (primary care, specialist, hospital)
• Dementia or Mild Cognitive Impairment diagnosis status (no
diagnosis, new diagnosis, old diagnosis)
• Follow-up (assessment with a MoCA or MMSE, or referral to a
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The use of cognitive testing in AWVs can lead to diagnosis of
dementia.
The presence of incompletely administered tests should warrant
further investigation into the flowsheet documentation process.
A standardized process for flagging abnormal scores may address
the issue of inconsistent follow-up.
The AWV should be seen as an opportunity to screen, rather than
diagnose, dementia. More widespread use of shorter tests such
as the Mini-Cog may make it more feasible to perform informal
cognitive screenings during an AWV while also creating a
dialogue for future follow-up.
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109 of 131 AWV patients expressed concerns about their memory on
their HRA questionnaire. 22 AWV patients did not express concerns
about their memory, but still completed a MMSE or MoCA
assessment. One such patient who did not express concerns about
memory had an abnormal MMSE score of 23, and consequently
received a geriatrics referral.
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